CD4 and cancer: HLA class II molecules like HLA-DPB1, HLA-DRA, HLA-DRB1, and HLA-DQB1 are associated with antigen processing and presentation to CD4+ T cells, and the down-regulation of these genes is related to poor prognosis of cancers [37, 38].